AT364359B - Verfahren zur herstellung von neuen aminoalkylidenamino-1,4-dihydropyridinen - Google Patents

Verfahren zur herstellung von neuen aminoalkylidenamino-1,4-dihydropyridinen

Info

Publication number
AT364359B
AT364359B AT0629677A AT629677A AT364359B AT 364359 B AT364359 B AT 364359B AT 0629677 A AT0629677 A AT 0629677A AT 629677 A AT629677 A AT 629677A AT 364359 B AT364359 B AT 364359B
Authority
AT
Austria
Prior art keywords
aminoalkylidenamino
dihydropyridines
producing new
producing
new
Prior art date
Application number
AT0629677A
Other languages
English (en)
Other versions
ATA629677A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ATA629677A publication Critical patent/ATA629677A/de
Application granted granted Critical
Publication of AT364359B publication Critical patent/AT364359B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT0629677A 1976-09-01 1977-09-01 Verfahren zur herstellung von neuen aminoalkylidenamino-1,4-dihydropyridinen AT364359B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762639257 DE2639257A1 (de) 1976-09-01 1976-09-01 Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
ATA629677A ATA629677A (de) 1981-03-15
AT364359B true AT364359B (de) 1981-10-12

Family

ID=5986848

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0629677A AT364359B (de) 1976-09-01 1977-09-01 Verfahren zur herstellung von neuen aminoalkylidenamino-1,4-dihydropyridinen

Country Status (12)

Country Link
US (1) US4146627A (de)
JP (1) JPS6026106B2 (de)
AT (1) AT364359B (de)
BE (1) BE858269A (de)
CH (1) CH634053A5 (de)
DE (1) DE2639257A1 (de)
ES (1) ES461994A1 (de)
FI (1) FI60862C (de)
FR (1) FR2363554A1 (de)
GB (1) GB1554495A (de)
NL (1) NL7709508A (de)
SE (1) SE7709797L (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2835069A1 (de) * 1978-08-10 1980-02-21 Bayer Ag N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung
NZ193167A (en) 1979-03-27 1984-08-24 Boots Co Plc Quinoline derivatives and pharmaceutical compositions
JPS58131982A (ja) * 1982-02-01 1983-08-06 Tokyo Tanabe Co Ltd 新規なる１．４−ジヒドロピリジン誘導体
US4419518A (en) * 1982-07-26 1983-12-06 Tokyo Tanabe Co. L.T.D. 1,4-Dihydropyridine derivatives
US4520131A (en) * 1983-03-03 1985-05-28 Usv Pharmaceutical Antihypertensive N-substituted 1,4-dihydropyridines
GR851819B (de) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
US4652573A (en) * 1985-03-14 1987-03-24 Nelson Research & Development Co. Calcium antagonist N-hetero ester 1,4-dihydropyridines
US4732898A (en) * 1986-04-29 1988-03-22 Warner-Lambert Company 2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
US5028708A (en) * 1987-04-14 1991-07-02 Sumitomo Chemical Company, Limited Azamethinyl quinoline derivatives
US5220027A (en) * 1987-04-14 1993-06-15 Sumitomo Chemical Company, Limited Sulfone-containing azamethide compounds with a nitrogen-containing aromatic ring of nitrogen containing aliphatic
GR1002248B (en) * 1988-03-08 1996-04-23 Egyt Gyogyszervegyeszeti Gyar 1,4-dihydropyridine derivatives preparation method
DE4313696A1 (de) * 1993-04-27 1994-11-03 Bayer Ag 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
JP3394215B2 (ja) 1999-07-29 2003-04-07 株式会社 日立インダストリイズ フィルム減圧貼り合わせ装置
WO2002079878A1 (fr) * 2001-03-29 2002-10-10 Hitachi Chemical Co., Ltd. Film photosensible pour la formation de circuit et procede de production de panneau de cablage de circuit imprime

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3946026A (en) * 1972-03-06 1976-03-23 Bayer Aktiengesellschaft 2-Amino-1,4-dihydropyridine derivatives
DE2239815C2 (de) * 1972-08-12 1983-02-10 Bayer Ag, 5090 Leverkusen 2-Alkylamino-dihydropyridine, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
ES461994A1 (es) 1978-12-01
US4146627A (en) 1979-03-27
FR2363554B1 (de) 1980-08-08
DE2639257A1 (de) 1978-03-02
CH634053A5 (de) 1983-01-14
GB1554495A (en) 1979-10-24
FR2363554A1 (fr) 1978-03-31
FI60862B (fi) 1981-12-31
JPS5331670A (en) 1978-03-25
FI772569A (fi) 1978-03-02
SE7709797L (sv) 1978-03-02
NL7709508A (nl) 1978-03-03
ATA629677A (de) 1981-03-15
FI60862C (fi) 1982-04-13
BE858269A (fr) 1978-02-28
JPS6026106B2 (ja) 1985-06-21

Similar Documents

Publication Publication Date Title
AT356827B (de) Verfahren zur herstellung von neuen spirol- actonen
AT358727B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT356136B (de) Verfahren zur herstellung von neuen spiro- hydantoinen
AT367401B (de) Verfahren zur herstellung von neuen 6-hydroxyalkyl-1,4-dihydropyridinverbindungen
AT364359B (de) Verfahren zur herstellung von neuen aminoalkylidenamino-1,4-dihydropyridinen
AT359187B (de) Verfahren zur herstellung von neuen 7-beta-(2- -oxyimino-2-arylacetamido)-cephalosporinen
AT363478B (de) Verfahren zur herstellung von neuen oxepanderivaten
AT350043B (de) Verfahren zur herstellung von neuen 3-polyhalogenaethyl-2, 2-dimethylcyclopropan- carbonsaeuren
AT370110B (de) Verfahren zur herstellung von neuen 4-androsten-3-onen
AT355305B (de) Verfahren zur herstellung von neuen ver- aetherten, elektrolytfreien methylolamino- triazinen
AT360185B (de) Verfahren zur herstellung von neuen dehydro- digopeptiden
AT343624B (de) Verfahren zur herstellung von neuen n-alkyl -2,4-dinitro-6- trifluormethyldiphenylaminen
AT353987B (de) Verfahren zur herstellung von neuen spirooxazolidindionen
AT362786B (de) Verfahren zur herstellung von neuen 1-acyl-2-imidazolinen
AT358726B (de) Verfahren zur herstellung von neuen cephalos- porinantibiotika
AT351191B (de) Verfahren zur herstellung von neuen d-homo- steroiden
AT364364B (de) Verfahren zur herstellung von neuen thiepinen
AT375931B (de) Verfahren zur herstellung von neuen aminoalkylfuranderivaten
AT356125B (de) Verfahren zur herstellung von neuen 1-aryloxy- -2,3-epoxypropanen
AT360646B (de) Verfahren zur herstellung von neuen cephalos- porinen
AT343623B (de) Verfahren zur herstellung von neuen n-alkyl -4-nitro-2- trifluormethyldiphenylaminen
ATA175879A (de) Verfahren zur herstellung von neuen antitumorglycosiden
ATA656076A (de) Verfahren zur herstellung von neuen d-homo- steroiden
ATA685879A (de) Verfahren zur herstellung von neuen 7alpha- -methoxy-7beta-(4-substituiert-methylen-1,3- -dithiaethan-2-yl)carboxymido-3-heterocyclisch- thiomethyl-delta3-cehpem-4-carbonsaeuren
ATA575379A (de) Verfahren zur herstellung von neuen keteniminen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee